| Overview |
| bsm-90273r-50µL |
| Glutamic-oxaloacetic transaminase 2 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human GOT2 |
| 17-72/430 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 2806 |
| P00505 |
| GOT2; Glutamic-Oxaloacetic Transaminase 2; KYAT4; Kynurenine Aminotransferase IV; MAspAT; KATIV; KAT4; Plasma Membrane-Associated Fatty Acid-Binding Protein; Glutamic-Oxaloacetic Transaminase 2 Mitochondrial; Aspartate Aminotransferase Mitochondrial; Kynurenine--Oxoglutarate Transaminase IV; Kynurenine--Oxoglutarate Transaminase 4; Glutamate Oxaloacetate Transaminase 2; Kynurenine Aminotransferase 4; Aspartate Aminotransferase 2; Fatty Acid-Binding Protein; Aspartate Transaminase 2; Transaminase A; EC 2.6.1.1; MitAAT; FABP-1; FABPpm; Glutamic-Oxaloacetic Transaminase 2 Mitochondrial (Aspartate Aminotransferase 2); EC 2.6.1.7; EC 2.6.1; MITAAT; DEE82 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz